| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MASH | Metabolic dysfunction-associated steatohepatitis |
| WLT | Weight loss target |
| CI | Confidence interval |
| ALT | Alanine aminotransferase |
| MRI | Magnetic resonance imaging |
| MRI-PDFF | Magnetic resonance imaging-based proton density fat fraction |
| LFC | Liver fat content |
| 2D-SWE | Two-dimensional shear wave elastography |
| WC | Waist circumference |
| BMI | Body mass index |
| FFA | Free fatty acid |
| FBG | Fasting glucose |
| FINS | Fasting insulin |
| UA | Uric acid |
| HOMA-IR | Homeostasis model assessment of insulin resistance |
| GGT | γ-glutamyl transpeptidase |
| LSM | Liver stiffness measurements |
| MVPA | Moderate-vigorous physical activity |
| LDL | Low-density lipoprotein cholesterol |
| TG | Triglyceride |